Servier, Qiagen to Develop PCR-Based Companion Diagnostic to Identify IDH1-Mutant Leukemia
Qiagen will develop a real-time PCR-based in vitro diagnostic to identify patients eligible for Servier's Tibsovo and investigational IDH1-targeted agents.
Blood-Based MRD Testing Identifies AML Patients at Risk of Relapse After Stem Cell Transplant
Researchers looked at AML variants in the blood of patients prior to their allogeneic hematopoietic cell transplant and correlated them with subsequent relapse or death.
The grant was recently awarded through the EU's Cancer Mission, a funding program to reduce cancer cases throughout the EU by 2030.
Thermo Fisher Scientific Obtains CE Mark for Ion Torrent Genexus Dx Integrated Sequencer
The company is developing a sample-to-report diagnostic workflow and a portfolio of clinically validated assays for the sequencing platform.
Precipio Hematologic Malignancy Test Receives NY State Approval
The Hemescreen test uses proprietary high resolution melt technology and can now be used in labs in New York as a laboratory developed test.